Linked Life Data

8332357

Source:http://linkedlifedata.com/resource/pubmed/id/8332357

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
1993-8-19
pubmed:abstractText
The appearance of systemic lupus erythematosus (SLE) as well as thymopoietin (TP3) treatment in a patient who has undergone thymectomy because of myasthenia gravis (MG) is described. To the authors' knowledge this is the first case of this treatment upon the diagnoses above. The therapy was performed for 12 weeks by the Hungarian Thymotrinan (TP3) preparate according to a previous protocol worked out for Hodgkin's disease. At the beginning and during therapy, cellular and humoral immune parameters were monitored. Twenty months after the therapy the patient has remained in clinical remission for both diseases, MG and SLE, respectively. There is a brief survey of the biochemistry of thymic hormones as well as their clinical use, especially in the treatment of autoimmune disorders. The relative rarity of SLE after operative treatment of MG is under discussion together with the effectiveness of substitutional thymic hormone therapy.
pubmed:language
hun
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0030-6002
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1369-72
pubmed:dateRevised
2009-10-21
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
[Incidence of SLE in a patient thymectomized for myasthenia gravis].
pubmed:affiliation
Semmelweis OTE Bör- és Nemikórtani Klinika, Budapest.
pubmed:publicationType
Journal Article, English Abstract, Case Reports